MiR-490-5p functions as tumor suppressor in childhood neuroblastoma by targeting MYEOV

Human Cell
Jinfeng WangXiang Li


Neuroblastoma (NB) is the most common extracranial solid tumor derived from neural crest in children. Recently, the role of miRNA has been studied extensively in the development of NB. Here, we investigated the clinical significance of microRNA-490-5p (miR-490-5p) in NB. A total of 72 pairs of NB tumor tissues and matched adjacent normal nerve tissues were collected from NB patients. The expression of miR-490-5p was significantly down-regulated in NB tissues and cell lines using quantitative real-time PCR. Using Pearson Chi-square test and Kaplan-Meier analysis, we found that significantly decreased miR-490-5p levels were correlated with INSS stage, lymph-node metastasis, and poor survival prognosis in NB patients. MiR-490-5p overexpression significantly suppressed cell proliferation migration, invasion, and induced cell cycle G0/G1 arrest and cell apoptosis in NB cell lines (SH-SY5Y and SK-N-SH) using CCK-8, flow cytometry, and transwell assays. Mechanistically, MYEOV was confirmed as a target gene of miR-490-5p by luciferase reporter assay. Furthermore, MYEOV knockdown imitated, while overexpression rescued the changes in the biological features of miR-490-5p on NB cells. Our results demonstrated for the first time that miR-4...Continue Reading


Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Johannes W G JanssenCharles Theillet
Jun 10, 2005·Nature·Jun LuTodd R Golub
Jul 13, 2005·Cell·Carlo M Croce, George A Calin
May 9, 2006·Biochemical and Biophysical Research Communications·Alan C MossPadraic MacMathuna
Jul 21, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alberto GaraventaRiccardo Haupt
Feb 2, 2010·Hematology/oncology Clinics of North America·Julie R ParkHuib Caron
Jun 24, 2010·Journal of Experimental & Clinical Cancer Research : CR·Garrett LawlorDavid W Murray
Jun 1, 2011·Cancer Science·Junko TakitaSeishi Ogawa
Dec 21, 2012·Pediatric Blood & Cancer·Julie R ParkUNKNOWN COG Neuroblastoma Committee
Nov 14, 2013·Biochemical and Biophysical Research Communications·Shiqi LiLiping Xie
Aug 12, 2014·CA: a Cancer Journal for Clinicians·Ioana Berindan-NeagoeGeorge A Calin
Nov 25, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Matthew J MurrayNicholas Coleman
Jul 1, 2017·Pediatric Hematology and Oncology·Atif A AhmedMaxine Hetherington
Feb 5, 2019·European Journal of Pharmacology·Xinru ChengQian Zhang

❮ Previous
Next ❯


Oct 24, 2020·Journal of Cellular Physiology·Omkar Suhas Vinchure, Ritu Kulshreshtha
Mar 16, 2021·Frontiers in Oncology·Omidvar RezaeiSoudeh Ghafouri-Fard

❮ Previous
Next ❯

Methods Mentioned

flow cytometry

Software Mentioned

pro plus

Related Concepts

Related Feeds


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis